INNOVATE Corp. (NYSE: VATE)

INNOVATE Corp. is a diversified holding company that manages a portfolio of subsidiaries across multiple industries, focusing on long-term value creation through sustainable free cash flow and attractive returns. The company operates as a strategic investor, targeting controlling positions in cash-generating businesses or high-growth potential ventures, primarily within infrastructure, life sciences, and spectrum sectors. INNOVATE actively evaluates acquisitions, divestitures, and organic growth opportunities to optimize its portfolio, aligning management incentives with stakeholder value. Its broad discretion in business strategy allows flexibility in pursuing opportunities both within and outside its core segments.

INNOVATE generates revenue through its operating subsidiaries, which provide specialized services and products tailored to distinct markets. The Infrastructure segment derives income from structural steel construction, fabrication, and industrial services, primarily under fixed-price or cost-plus contracts. The Life Sciences segment commercializes medical and aesthetic technologies, earning revenue from product sales, licensing agreements, and royalties. The Spectrum segment monetizes over-the-air broadcasting through channel leases and revenue-sharing agreements with content providers. Additional revenue streams come from early-stage healthcare investments and other miscellaneous businesses.

The company operates through the following segments:

• Infrastructure: This segment, led by DBM Global Inc., delivers fully integrated structural and steel construction services, including design-assist, fabrication, erection, and industrial maintenance. It serves commercial, industrial, and infrastructure projects such as high-rise buildings, data centers, power plants, and sports arenas. The segment also manufactures pressure vessels and specialized equipment for the oil, gas, and petrochemical industries. DBM Global operates domestically and internationally, leveraging digital engineering and predictive technologies to enhance project delivery and efficiency.

• Life Sciences: This segment, anchored by Pansend Life Sciences, focuses on developing and commercializing healthcare and biotechnology products. It holds controlling interests in companies like R2 Technologies, which specializes in aesthetic medical devices for skin lightening and inflammation reduction, and Genovel Orthopedics, which develops knee osteoarthritis treatments. Additional investments include MediBeacon, a medical technology firm advancing fluorescent tracer agents for kidney function monitoring, and early-stage ventures in cell therapy and medical device engineering.

• Spectrum: This segment, managed by HC2 Broadcasting Holdings Inc., operates a network of over-the-air television stations across the U. S. and Puerto Rico. It generates revenue by leasing sub-channels to content providers under fixed-fee or revenue-sharing agreements. The segment capitalizes on the growing over-the-air viewing market, utilizing cloud-based infrastructure to reduce operational costs and explore emerging technologies like ATSC 3.0 for datacasting and 5G broadcasting.

• Other: This segment includes businesses that do not meet the thresholds for separate reporting, such as minor investments and non-core assets.

INNOVATE occupies a unique position within its industries, leveraging diversification to mitigate sector-specific risks while capitalizing on niche opportunities. In the Infrastructure segment, DBM Global competes with regional and national construction firms but distinguishes itself through its integrated service model, digital engineering capabilities, and large-scale project execution. Its ability to handle complex, high-margin projects with fewer competitors enhances its market standing. In Life Sciences, the company faces competition from established medical technology and aesthetic product firms but differentiates itself through proprietary technologies like CryoModulation and breakthrough devices such as the Glacial Rx system. The Spectrum segment contends with traditional broadcasters, streaming services, and digital platforms but benefits from its extensive station footprint and cost-efficient, cloud-based operations. Across all segments, INNOVATE’s competitive advantages include its strategic focus on scalable, cash-generating assets and its ability to align management incentives with long-term growth.

INNOVATE’s customer base spans a broad range of industries and geographies. The Infrastructure segment serves general contractors, architects, engineers, original equipment manufacturers, and industrial owners, including commercial developers and government agencies. Notable customers have included large construction and engineering firms, though specific names are not disclosed. The Life Sciences segment targets healthcare professionals, medical practices, spas, and international distributors, with R2 Technologies’ products sold through direct sales forces in the U. S. and Canada and distributors in markets like China, Mexico, and the United Arab Emirates. The Spectrum segment’s customers are primarily content providers and multicast network tenants seeking nationwide over-the-air distribution. The company’s diversified customer base reduces reliance on any single client, though concentration risks exist within individual segments.